This announcement is a separate document:
赛托生物：国金证券股份有限公司关于山东赛托生物科技股份有限公司2023年度内部控制评价报告的核查意见
Shandong Sito Bio-technology: Guojin Securities Co., Ltd. inspection opinions on the 2023 internal control evaluation report of Shandong Saito Biotechnology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated